Large Volume Wearable Injectors Market to Post Over 150% CAGR to 2027, Expects Roots Analysis in Its Report Available at MarketPublishers.com
07 Mar 2017 • by Natalie Aster
LONDON – With the rising incidence rate of chronic and lifestyle diseases worldwide, the requirement of effective drug delivery systems is gaining rapid momentum. With a view to simplifying drug delivery process, decreasing the incidence rate of percutaneous injuries and eliminating costs, the pharma industry is currently focused on the development of self-injection devices for parenteral drug therapies.
More than 50 various large volume wearable injectors are either commercialised or under development. Of these, close to 60% are mean for insulin delivery and the rest are for the delivery of other biological drugs.
There are some other references of drug-device combinations being assessed in clinical trials. Amid the examples one can name SteadyMed Therapeutics’ patchpump, NeuroDerm’s CRONO ND, and Roche’s single-use injection devices, among others.
Around 100 biologics are suitable for delivery by means of large-volume wearable injectors and are expected to be evaluated in various drug-device combination products at an early date. These biologics are designed to treat chronic illnesses, which need frequent dosing, and are not presently available in relevant self-administration systems. Some of these medications, are projected to make give a boost to the growth of the market in the years to come.
Globally, the market for large-volume wearable injectors is poised to expand at an immense rate of more than 150%. OmniPod is projected to keep on dominating the insulin delivery marketplace. Though, the growth is mainly to be driven by drug-device combinations under clinical trials for non-insulin biologic drugs. The annual sales of these devices is forecast to surpass 40 million units in volume by end-2027.
New research report “Large Volume Wearable Injectors Market (3rd Edition), 2017-2027” drawn up by Roots Analysis provides an insightful guide to the market on a global level.
The research study extensively examines the present-day landscape and the prospective evolution of the sector over the next decade. It discusses the key market players, development status of pipeline products, type of dose, usability and key indications. The report provides detailed profiles of the products developed for the delivery of biologics, limelighting key features, present-day development status, latest developments and related collaborations. It gives an exhaustive review of over 300 biologics, which are prospective candidates for the delivery via large-volume wearable injectors. The report includes exhaustive case studies on drugs which are being examined for the delivery using large-volume wearable injectors. The study presents a discussion on the major challenges and drivers, with regard to the SWOT, that will likely influence the growth of this area in the offing.
More comprehensive market research studies by Roots Analysis are available at its page.